Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-06-01
1996-10-22
Burn, Brian
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514568, A61K 3138
Patent
active
055677240
ABSTRACT:
The present invention provides a method of inhibiting .beta.-amyloid toxicity in brain cells. The method includes administering to the cells an amount of an alkaline phosphatase inhibitor which is pharmacologically effective to reduce degeneration in the cells. Methods of treatment of peripheral neuropathy are also provided using acid or alkaline phosphatase inhibitors.
REFERENCES:
patent: 4701407 (1987-10-01), Appel
patent: 4727041 (1988-02-01), Aroonsakul
patent: 4753964 (1988-06-01), Horrobin
patent: 4758430 (1988-07-01), Sabin
patent: 4810497 (1989-03-01), Horrobin
patent: 4837164 (1989-06-01), Glick
patent: 4874694 (1989-10-01), Gandy
patent: 4883876 (1989-11-01), Nakatsuka
patent: 4939124 (1990-07-01), Cacabelos
patent: 4939175 (1990-07-01), Ukai
patent: 4973591 (1990-11-01), Selkirk
patent: 5017470 (1991-05-01), Aroonsakul
patent: 5063220 (1991-11-01), Selkirk
patent: 5100654 (1992-03-01), Ali-Khan
patent: 5135847 (1992-08-01), Hoke
patent: 5151508 (1992-09-01), Salbaum
patent: 5200324 (1993-04-01), Navaratnam
patent: 5206260 (1993-04-01), Hichens
patent: 5223482 (1993-06-01), Schilling
patent: 5234814 (1993-08-01), Card
patent: 5246944 (1993-09-01), Greenlee
patent: 5260210 (1993-11-01), Rubin
patent: 5270165 (1993-12-01), Van Nostrand
Ishi, Tsuyoshi (1969) "Enzyme Histochemical Studies of Senile Plaques and the Plaque-Like Degeneration of Arteries and Capillaries (Scholz)", Acta neuropath. 14:250-260.
Op Den Velde, W. et al. (1976) "Some Cerebral Proteins and Enzyme Systems in Alzheimer's Presenile and Senile Dementia", Journal of the American Geriatrics Society, XXIV(1):12-16.
Kawai, Mitsuru, et al. (1992) "Subcellular Localization of Amyloid Precursor Protein in Senile Plaques of Alzheimer's Disease", American Journal of Pathology, 140(4):947-958.
Armbruster, David A., et al. (1988) "The regional variability of enzymes in the brain: relevance to CSF enzyme determinations", Clinica Chimica Acta, 175:227-238.
Kraus, Arthur S., et al. (1992) "Aluminum, Fluoride and the Prevention of Alzheimer's Disease", Canadian Journal of Public Health, 83 (2):97-100.
Sofic, E., et al. (1991) "Biochemical Membrane Constituents and Activities of Alkaline and Acid Phosphatase and Cathepsin in Cortical and Subcortical Brain Areas in Dementia of the Alzheimer Type", Dementia, 2:39-44.
Ohmar, Rawhi, et al. (1993) "Acid Phosphatase Activity in Senile Plaques and Cerebrospinal Fluid of Patients with Alzheimer's Disease", Arch Pathol Lab Med, 117:166-169.
Shimohama, Shun, et al. (1993) "Reduction of Low-Molecular-Weight Acid Phosphatase Activity in Alzheimer Brains", Ann Neurol 33:616-621.
Rush, D. N., et al. (1980) "The Effect of Levamisole In Experimental Murine Amyloidosis", Journal of Immunopharmacology, 2(4):553-565.
Eveleth David D.
Kelleher Judith A.
Burn Brian
Cortex Pharmaceuticals, Inc.
LandOfFree
Alkaline and acid phosphatase inhibitors in treatment of neurolo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkaline and acid phosphatase inhibitors in treatment of neurolo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkaline and acid phosphatase inhibitors in treatment of neurolo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2358919